We are live on ! Find out more
IART icon

Integra LifeSciences

194 hedge funds and large institutions have $2.2B invested in Integra LifeSciences in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

42% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 62

4% more funds holding

Funds holding: 186194 (+8)

4% more capital invested

Capital invested by funds: $2.12B → $2.2B (+$77M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
194
Holders Change
+8
Holders Change %
+4.3%
% of All Funds
5.17%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
21
Increased
88
Reduced
62
Closed
12
Calls
$209K
Puts
Net Calls
+$209K
Net Calls Change
+$146K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$3.53M +$1.62M +51,938 +98%
New York State Teachers Retirement System (NYSTRS)
77
New York State Teachers Retirement System (NYSTRS)
New York
$3.51M +$6.23K +200 +0.2%
GTC
78
Ghost Tree Capital
New York
$3.37M -$4.36M -140,000 -58%
RhumbLine Advisers
79
RhumbLine Advisers
Massachusetts
$3.26M +$197K +6,320 +7%
Swiss National Bank
80
Swiss National Bank
Switzerland
$3.16M +$635K +20,400 +27%
AllianceBernstein
81
AllianceBernstein
Tennessee
$2.86M
UBS AM
82
UBS AM
Illinois
$2.83M -$193K -6,198 -7%
ICRM
83
Insight Capital Research & Management
California
$2.73M +$2.52M +81,042 New
BG
84
BlackRock Group
United Kingdom
$2.47M +$206K +6,612 +10%
Macquarie Group
85
Macquarie Group
Australia
$2.37M
AIG
86
American International Group
New York
$2.34M +$145K +4,656 +7%
DekaBank Deutsche Girozentrale
87
DekaBank Deutsche Girozentrale
Germany
$2.28M -$417K -13,400 -17%
Renaissance Technologies
88
Renaissance Technologies
New York
$2.25M -$1.12M -36,000 -35%
Susquehanna International Group
89
Susquehanna International Group
Pennsylvania
$2.22M +$669K +21,468 +48%
BPIM
90
Brant Point Investment Management
New York
$2.1M -$4.67M -150,000 -71%
Comerica Bank
91
Comerica Bank
Texas
$2M +$1.31K +42 +0.1%
HMS
92
Hanseatic Management Services
New Mexico
$1.62M +$1.5M +48,094 +48,094%
SDIC
93
South Dakota Investment Council
South Dakota
$1.56M
TPSF
94
Texas Permanent School Fund
Texas
$1.55M -$46K -1,476 -3%
RJA
95
Raymond James & Associates
Florida
$1.55M +$22.5K +722 +2%
State of Tennessee, Department of Treasury
96
State of Tennessee, Department of Treasury
Tennessee
$1.53M +$33.3K +1,070 +2%
Citigroup
97
Citigroup
New York
$1.52M +$1.25M +40,260 +849%
DVM
98
Dreman Value Management
Florida
$1.5M +$1.39M +44,516 New
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$1.43M +$106K +3,390 +9%
Public Sector Pension Investment Board (PSP Investments)
100
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.37M

IART Hedge Fund Activity: Q1 2016 in Review

194 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2016, worth a combined $2.2B — up 3.6% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IART positions and 12 closed out — a net gain of 9 holders — while 88 added to existing stakes and 62 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $51.5M.

  • 194 institutional investors held Integra LifeSciences (IART) as of Q1 2016, up from 186 in Q4 2015.
  • Funds reported $2.2B of Integra LifeSciences stock for Q1 2016, up 3.6% quarter-over-quarter.
  • 21 funds opened new Integra LifeSciences positions in Q1 2016 and 12 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q1 2016 was Lord, Abbett & Co, an estimated $25.4M added.
  • The largest Integra LifeSciences seller in Q1 2016 was Fidelity Investments, an estimated $51.5M sold.

Based on aggregated 13F filings for Q1 2016.